Breaking Out of the Bubble

X-linked severe combined immunodeficiency (X-SCID, or SCID-X1), is an orphan monogenic disorder popularly known as ‘bubble boy disease’ that affects 1 in 50,000-100,000 live births. The most serious of all primary immunodeficiencies, X-SCID causes severe failure of the immune system,… Read »

Meet You at ASCO!

ASCO, the world’s largest meeting focused on cancer, is always one of the highlights of our calendar here at Bionest. This year is no exception and several of us are headed to Chicago for this year’s event, which is being… Read »

Join Us at BIO for “Precision Medicine Beyond Oncology”

The original vision of “personalized medicine” focused on tailoring medications to the biology of the individual patient — treating them with the right drug at the right time. That view has since evolved beyond therapy selection to increasingly encompass aspects… Read »

Innovation in HIV Therapies Improve Options for Care

Considerable progress has been made in the fight against HIV/AIDS since the first cases of the disease in the 1980s. Today, successful antiretroviral drug regimens are able to reduce viral loads to undetectable levels, cutting the risk of transmission almost… Read »

Virtual Reality Advances Aiding Surgical Education

Virtual reality, the simulation of an environment that a user can interact with, and augmented reality, the superimposition of computer-generated images and sounds onto the real world, have gained the widespread use in video games and 3-D movies. But surprisingly,… Read »

Landmark Approvals in Depression

Depression is a challenging condition to treat. Most antidepressants take four to six weeks to take effect, and patient response to such drugs varies widely from person to person. As a result, most patients must try several drugs over a… Read »

Next Generation Pills

Few people like injections, which can limit adherence to therapy and even cause some patients to avoid potentially beneficial treatments altogether. As a result, drug developers have commonly viewed oral delivery as the “gold standard” for many therapies, especially for… Read »

FDA Fosters Innovation in Diabetes Care Through New Device Classification

Digital technologies are becoming an increasingly important part of modern healthcare. Medical devices  have the ability to connect to and communicate with other devices or systems. Not only are new types of devices being created, but many existing devices are… Read »

Bifunctional Antibodies: The Next Generation of Immuno-oncology Agents

Immuno-oncology agents, particularly checkpoint inhibitors, have moved to the forefront of cancer research and treatment in recent years. Indeed, the discovery that cancer could be treated by activating the immune system was honored with a Nobel Prize in 2018. But,… Read »

Alzheimer’s Disease Update

Scientific evidence increasingly points to brain inflammation as a major driver of Alzheimer’s disease (AD). Researchers have discovered that amyloid, one of the hallmarks of the disease, is antimicrobial and may help the immune system fight invaders to the brain…. Read »

1 2 3 16